[To promote the clinical application of PET/MRI in oncology].
Zhonghua Yi Xue Za Zhi
; 103(33): 2543-2545, 2023 Sep 05.
Article
em Zh
| MEDLINE
| ID: mdl-37650200
ABSTRACT
PET/MRI integrates anatomical, functional and metabolic information, and is increasingly used in the field of clinical oncology, including early diagnosis of disease, local staging, detection of systemic metastases, evaluation of treatment efficacy and prognosis. In addition to fine anatomical structure, MRI multiparametric imaging can also provide functional information of the lesion. Combined with metabolic information of PET, MRI multiparametric imaging can better evaluate the benign and maligant lesions, tumor grade and extent of invasion, and identify tumor recurrence and radiation necrosis. The development of new PET tracers, optimization of MRI sequences and examination paths, combined with high-throughput image quantitative analysis methods, radiomics, artificial intelligence and other new technologies will further promote the application of PET/MRI in oncology.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Lesões por Radiação
/
Inteligência Artificial
Idioma:
Zh
Ano de publicação:
2023
Tipo de documento:
Article